Clinical trial · Observational
The BRAvAdO Registry
BRAzilian Registry of Acute Coronary Syndrome in Oncologic Patients - The BRAvAdO Registry
NCT04222608CI-TRIAL-00042678BRAvAdOunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The BRAVADO Registry pretends to identify stratification, diagnosis, total atherosclerotic burden and treatment approaches in oncologic patients with Acute Coronary Syndrome (ACS) and identify strategies to improve health care quality
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| ACS - Acute Coronary Syndrome | — | UNRESOLVED | — |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (3)
- measure
- Major adverse cardiovascular events
- timeFrame
- 30 days
- description
- Composite endpoint of All-cause Death, Myocardial Infarction, Stroke and Myocardial Revascularization
- measure
- Total Atherosclerotic burden and lesion complexity on angiography
- timeFrame
- 30 days
- description
- The number and location of coronary lesions with obstructions greater than 50% were recorded. Each lesion was classified based on Ambrose's, Goldstein complexity, Leaman and SYNTAX scores.
- measure
- Incidence of Major Bleeding
- timeFrame
- 30 days
- description
- Requiring a transfusion of ≥2 U PRBCs Resulting in a decrease in hematocrit of ≥10% Occurring intracerebrally Resulting in stroke or death
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Definitive cancer diagnosis - biopsy * Acute Coronary Syndrome - requiring urgent invasive risk stratification Exclusion Criteria: * KPS \< 60 , ECOG \>/ 3 * Life expectancy less 24hs * End of Life Care * Lack of consistent record data
References
Publications (1)
- DERIVEDSeleme VB, da Silva Costa IBS, Pileggi B, de Barros Branco CE, Rizk SI, de Medeiros Lopes MAAA, Campanha Borges DC, Campos RN, de Brito FS, Abdalla Sanches JM, Godinho RR, Esper RB, Faillace B, Precoma DB, Ribeiro MH, Seabra-Garcez JD, Nunes Ferreira AF, Kalil Filho R, Abizaid A, Hajjar LA, Campos CM. Association of cancer on coronary atherosclerotic burden and plaque rupture: Insights from the BRAVADO study. Atherosclerosis. 2026 Apr;415:120683. doi: 10.1016/j.atherosclerosis.2026.120683. Epub 2026 Feb 19. PMID 41763067